Get started

Cannabis

Is MJ about to get high?Marijuana stocks have been on the decline for a while, but things may soon start turning around. Last month, the House Judiciary Committee advanced HR 3617 or (MORE) Act of 2021, a bill that repeals the long-standing federal prohibition of marijuana by removing it from the Controlled Substances Act — thereby ending the existing state/federal conflict in cannabis policies and providing state governments with greater authority to regulate marijuana-related activities, including retail sales. What the MORE Act Does: The legislation’s provisions remove marijuana from the federal Controlled Substances Act — thereby eliminating the existing conflict between state and federal marijuana laws and providing states with the authority to be the primary arbiters of cannabis policy within their jurisdictions. If passed HR 3617 would facilitate the expungement of low-level federal marijuana convictions, create pathways for ownership opportunities in the emerging regulated industry, and allow veterans to obtain medical cannabis among other things. Source I chose MJ to gain exposure to the global cannabis industry. AUM: 1 Billion TOP 10 FUND HOLDINGS (%) Grow Generation Corp: 9.66 Tilray Inc: 9.43 Canopy Growth Corp: 7.80 Aurora Cannabis Inc: 6.61 Cronos Group Inc: 6.42 Hexo Corp: 4.76 Organigram Hldgs Inc: 4.20 Village Farms Intl Inc: 3.92 22nd Centy Group Inc: 3.46 Arena Pharmaceuticals Inc: 3.26 Prospectus Fact Sheet Holdings Technicals Price action and RSI diverging for the past three months with PA finding support at about $14.00 since the bill was advanced RSI moving to potentially break above 50 and could correspond to a breakout of the descending wedge Price holding at about the Fib Extension level of 61.8%, will watch these levels closely as PA advances or declines The Trade With confidence that there will be further potential bullish sentiment for the cannabis industry on the horizon, I will be preempting a breakout and taking a position at current levels. Bull Case TP1 set at about $17.50 TP2 set at about $25 Anticipate resistance at about $16-$17 Will be watching price action closely below the $17.50 region as a substantial pullback could fill out a possible right shoulder of a head and shoulders pattern before retesting trend line and breaking low. Bear Case Price action rejection at resistance level at around $15.50 could push price down and make lower lows on the daily chart If a price drop occurs, I will be watching for support at around the $13.50 region or Fib 50% level Will look to exit position if weekly close is below $13.00 with RSI levels pushing down to or below 38.2 Approximate risk of loss on trade from current levels is about 12%-15%
AMEX:MJLong
by spreck
3
TILRAY ROCKET HIGH TODAY +16% This is not an advice just a note for myself to remember. Months it was low and today it flew 16% up to 11.83 (came from prox 10) It had no pullback and no backtest of the opening which TIlray normally does. This makes me wonder if this high is sustainable. I think it will not go that easy tomorrow to 15 or higher....I think it will test the opening price once more. Or at least test 50% of this rise of 16%. I am afraid to buy more because it can drop very fast. Tilray does not have good numbers only good news of legalisation and some products possible with cannabis in it.....I don't see a further rise this easy. Feel free to share your point of view with me or share a nice analysis with me. I know the price is very far from the ATH -75% i think.
NASDAQ:TLRY
by megustadinerow
2
small cap growth stock to watch out forHexo is literally a small cap growth stock. The recent drop in share price was understandable because of the 140m offering and securing 360m in debt both of which are being used to acquire Redecan which is an extremely popular LP in Canada from the Q3 financials Under the terms of the Share Purchase Agreement, the $925 million purchase price will be paid to the Redecan shareholders as $400 million of consideration due on closing paid in cash and $525 million of consideration due on closing paid through the issuance of HEXO common shares at an implied price per share of $7.53. Cannabis growth is a complicated and risky market. Something Hexo has shown a keen eye for to capitalize on acquisitions during the springs announcements and buzz around cannabis stocks in general. Hexo continues its aggresive growth in the Canadian sector with footholds into European and US cannabis markets. Redecan adds a strong brand recognition, leading cannabis growth, cultivation and distribution innovation and positive cash flows that Hexo was struggling with. 370M Market Cap is well oversold for what I believe is nearing the bottom of Mark down after distribution from the spring months. I'm not a financial advisor. Not that there is anything wrong with that. This is not financial advice in anyway. Hexo is a value stock with tremendous growth and future but it also presents greater risk. I plan on entering a position when i see signs of the next accumulation phase beginning.
HLong
by SPYvsGME
US10Y - Rising Rates Environment - Go Small Cap Gems - Valuation#MSOgang #cannabisreform #epiceconomics #thegem $GNLN The War on Drugs has been a war on people—particularly people of color. The Cannabis Administration and Opportunity Act aims to end the decades of harm inflicted on communities of color by removing cannabis from the federal list of controlled substances and empowering states to implement their own cannabis laws. Federal cannabis reforms are especially urgent as more and more states legalize the adult and medical use of cannabis. To date, the adult use of cannabis is legal in 18 states, the District of Columbia, the Commonwealth of the Northern Mariana Islands, and Guam; and 37 states, the District of Columbia, Puerto Rico, Guam, and the U.S. Virgin Islands have advanced laws to allow medical cannabis, with nearly all Americans living in a state where some form of cannabis is legal. These changes represent a dynamic shift in public opinion and support across the political spectrum. Today, more than 90 percent of Americans believe cannabis should be legal either for adult or medical use. Despite legalization under state law and broad public support for cannabis legalization, cannabis remains illegal under federal law. By ending the failed federal prohibition of cannabis, the Cannabis Administration and Opportunity Act will ensure that Americans – especially Black and Brown Americans – no longer have to fear arrest or be barred from public housing or federal financial aid for higher education for using cannabis in states where it’s legal. State-compliant cannabis businesses will finally be treated like other businesses and allowed access to essential financial services, like bank accounts and loans. Medical research will no longer be stifled. But this alone is not enough. The Cannabis Administration and Opportunity Act includes restorative measures to lift up people and communities who were unfairly targeted in the War on Drugs. The bill automatically expunges federal non-violent marijuana crimes and allows an individual currently serving time in federal prison for non-violent marijuana crimes to petition a court for resentencing. The legislation also creates an “Opportunity Trust Fund” funded by federal cannabis tax revenue to reinvest in the communities most impacted by the failed War on Drugs, as well as helping to level the playing field for entrepreneurs of color who continue to face barriers of access to the industry. Importantly, the legislation also ends discrimination in federal public benefits for medical marijuana patients and adult use consumers. The legislation preserves the integrity of state cannabis laws and provides a path for responsible federal regulation of the cannabis industry. Like with federal regulations on alcohol, CANNABIS ADMINISTRATION AND OPPORTUNITY ACT | Sens. Booker, Wyden, and Schumer 2 states can determine their own cannabis laws, but federal prohibition will no longer be an obstacle. Regulatory responsibility will be moved from the U.S. Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), the Bureau of Alcohol Tobacco Firearms and Explosives (ATF), as well as the Food and Drug Administration (FDA) to protect public health. Additionally, revenue generated by federal taxes will support restorative justice and public health and safety research. U.S. Senators Cory Booker, D-N.J., Ron Wyden, D-Ore., and Chuck Schumer, D-N.Y., (collectively referred to in this document as the “Sponsoring Offices”) are committed to turning the page on this sad chapter in American history and undoing the devastating consequences of current discriminatory cannabis policies. Crypto to Cannabis. AGAIN!
TVC:US10Y
by EpicEconomics
3
Looking for a bounceDaily RSI at historic Oversold bounce levels. Almost as beat up as the covid crash right now. In the past we have bounced 25%-80%+ when bouncing off this level of Oversold conditions. There is also a gap on the daily now above at these extreme conditions that needs to be filled Also in a buy/support zone on the daily Weekly Oversold 4HR at historic Oversold bounce levels 1HR at historic Oversold bounce levels Daily looking to like a potential falling wedge, at price support/buy zone, at historic oversold levels with now a daily gap above to fill. A lot of confluence and the stars aligning for a good multi-day/weekly bounce out of OS conditions
NASDAQ:CGCLong
by Natestradamus
TLRY: Time to get high?Just bought Tilray🌿 stocks @ 12.22, currently at trendlines & previous significant high confluence. Price needs to break up the red falling wedge. Target 122 which means 10x. The blue uptrendline on log scale (imo false break down) and also higher volume this year shown below: Please like👍, comment🗣️, follow me✒️, enjoy📺! Disclaimer: I'm not financial advisor. This is not a financial advice. Do your own due dilingence. NASDAQ:TLRY TSX:TLRY CAPITALCOM:TLRY FTX:TLRYUSD SIX:2HQ NEO:TLRY SWB:2HQ XETR:2HQ FWB:2HQ MUN:2HQ HAM:2HQ HAN:2HQ BER:2HQ FTX:TLRY0924 NASDAQ:NDAQ OANDA:NAS100USD CURRENCYCOM:US100
NASDAQ:TLRYLong
by bizmark
2